Emmrich S, Wang W, John K, Li W, Pützer BM.
Specific LNA-ASOs against oncogenic p73 isoforms permit therapeutic cancer targeting in vivo.
Hum Gene Ther 2010; 21:1205-1206.
Vorheriger Beitrag
E2F1 Determines Melanoma Progression and Metastasis via EGF Receptor Signaling.
Nächster Beitrag
Cancer specific peptide-tagged Ad vectors in systemic therapy of aggressive solid tumors.